Intervention Review

You have full text access to this OnlineOpen article

Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis

  1. Graziella Filippini1,*,
  2. Cinzia Del Giovane2,
  3. Laura Vacchi3,
  4. Roberto D'Amico2,
  5. Carlo Di Pietrantonj4,
  6. Deirdre Beecher5,
  7. Georgia Salanti6

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group

Published Online: 6 JUN 2013

Assessed as up-to-date: 10 FEB 2012

DOI: 10.1002/14651858.CD008933.pub2

How to Cite

Filippini G, Del Giovane C, Vacchi L, D'Amico R, Di Pietrantonj C, Beecher D, Salanti G. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD008933. DOI: 10.1002/14651858.CD008933.pub2.

Author Information

  1. 1

    Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Neuroepidemiology Unit, Milano, Italy

  2. 2

    University of Modena and Reggio Emilia, Statistics Unit, Department of Clinical and Diagnostic Medicine and Public Health, Modena, Italy

  3. 3

    Scientific Institute and University Ospedale San Raffaele, Institute of Experimental Neurology (INSPE), Milano, Italy

  4. 4

    Azienda Sanitaria Locale ASL AL, Servizio Regionale di Riferimento per l'Epidemiologia, SSEpi-SeREMI - Cochrane Vaccines Field, Alessandria, Piemonte, Italy

  5. 5

    London School of Hygiene & Tropical Medicine, Cochrane Injuries Group, London, UK

  6. 6

    University of Ioannina School of Medicine, Department of Hygiene and Epidemiology, Ioannina, Greece

*Graziella Filippini, Neuroepidemiology Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, via Celoria, 11, Milano, 20133, Italy. gfilippini@istituto-besta.it.

Publication History

  1. Publication Status: New
  2. Published Online: 6 JUN 2013

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    R. Reindel, J. Bischof, K.-Y. A. Kim, J. M. Orenstein, M. B. Soares, S. C. Baker, S. T. Shulman, E. J. Perlman, M. W. Lingen, A. J. Pink, C. Trevenen, A. H. Rowley, CD84 is markedly up-regulated in Kawasaki disease arteriopathy, Clinical & Experimental Immunology, 2014, 177, 1
  2. 2
    Nikolai Pfender, Roland Martin, Daclizumab (anti-CD25) in multiple sclerosis, Experimental Neurology, 2014,

    CrossRef

  3. 3
    N. Melzer, S. G. Meuth, Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies, Clinical & Experimental Immunology, 2014, 175, 3
  4. 4
    Peter Leiner, Was nützt MS-Patienten am meisten?, InFo Neurologie & Psychiatrie, 2013, 15, 9, 8

    CrossRef

  5. 5
    Rachel Riera, Gustavo Porfirio, Cristine R Migliorini, Maria R Torloni, Alemtuzumab for multiple sclerosis, The Cochrane Library,
  6. 6
    Zhu Xu, Feng Zhang, FangLi Sun, KeFeng Gu, Shuai Dong, Dian He, Dimethyl fumarate for multiple sclerosis, The Cochrane Library,
  7. 7
    Dian He, Rui Guo, Fubo Zhang, Chao Zhang, Shuai Dong, Hongyu Zhou, Rituximab for relapsing-remitting multiple sclerosis, The Cochrane Library,